The Effect of Pre-exercise Feeding on Bone Turnover Biomarkers
The Influence of Pre-exercise Feeding on Acute Bone Turnover Biomarkers in Response to Physical Activity in Healthy Participants
1 other identifier
interventional
16
0 countries
N/A
Brief Summary
Osteoporosis is a major contributor to loss of independence due to bone fractures and resulting hospital treatments lead to significant morbidity. While pharmacological treatments can reduce consequences of osteoporosis, there is a pressing need for non-pharmacological interventions to improve bone health across the life-course and to reduce likelihood of age-related bone disease. This study will allow us to determine whether synergistic potentiating effects on bone metabolism are observed in humans in relation to the timing of food ingestion and what recommendations can be made to people with respect to food ingestion and exercise to obtain the maximal bone benefits from aerobic exercise. Furthermore, if we can identify interventions that potentiate bone's response to aerobic exercise in younger adults, then such interventions may have the ability to maximise bone mass in younger adults so that with ageing, the additional bone mineral density and improved bone microarchitecture would extend the time before osteoporotic "fracture thresholds" are reached. Therefore, understanding the bone metabolic response to exercise following fasting and feeding in younger adults is important.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2024
CompletedFirst Posted
Study publicly available on registry
August 13, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedAugust 13, 2024
August 1, 2024
5 months
July 30, 2024
August 8, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
C-terminal telopeptide of type-1 collagen (CTX-1)
The primary endpoint of this study is the change of the bone resorption biomarker C-terminal telopeptide of type-1 collagen (CTX-1) expression
Between pre-exercise and 2 hours following the exercise timepoints
Secondary Outcomes (4)
Procollagen type 1 N-terminal propeptide (P1NP)
Between pre-exercise and 2 hours following the exercise timepoints
Cortisol
Between pre-exercise and 2 hours following the exercise timepoints
Insulin
Between pre-exercise and 2 hours following the exercise timepoints
Glucose
Between pre-exercise and 2 hours following the exercise timepoints
Study Arms (3)
Breakfast only
EXPERIMENTALBreakfast only without the exercise protocol
FAST
EXPERIMENTALParticipants will be exercised 90 minutes following a 12-hour overnight fast
FED
EXPERIMENTALParticipants will be exercised 90 minutes after a meal
Interventions
Participants will attend a breakfast-only arm without the exercise protocol.
Eligibility Criteria
You may qualify if:
- Male (females excluded to remove the interplay between menstrual cycle and bone turnover)
- Caucasian ethnicity
- Aged 28 ± 4 years
- Are physically active (meet the UK guidelines for physical activity of at least 150 minutes moderate intensity activity and/or at least 75 minutes of vigorous intensity activity per week)
- Otherwise, healthy, able and willing to participate and provide written informed consent
You may not qualify if:
- Current smokers
- Excessive alcohol consumption (max 15 alcohol units/week)
- Any musculoskeletal injury/disabilities
- Any conditions known to affect bone metabolism (e.g. uncontrolled hyper-/hypothyroidism, hyperparathyroidism, hypo-/hypercalcaemia) or malabsorption syndromes (e.g. Crohn's disease, coeliac disease or inflammatory bowel disease).
- Taking any medication known to affect bone metabolism (such as glucocorticoids or bisphosphonates)
- Positive Covid-19 test within the last 8 weeks
- Suffered a fracture in the previous 12 months
- Have been told by medical professionals that they should not take part in moderate to high intensity exercise
- Should not be a professional athlete or take part in significant competitive recreational activity (takes no more than 4 structured exercise sessions per week on average)
- History of diagnosed eating disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sheffield Hallam Universitylead
- Anglia Ruskin Universitycollaborator
- University of Sheffieldcollaborator
- Manchester Metropolitan Universitycollaborator
- Sheffield Teaching Hospitals NHS Foundation Trustcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2024
First Posted
August 13, 2024
Study Start
October 1, 2024
Primary Completion
March 1, 2025
Study Completion
June 1, 2025
Last Updated
August 13, 2024
Record last verified: 2024-08